ImageneBio Files 424B3 Prospectus

Ticker: IMA · Form: 424B3 · Filed: Apr 13, 2026

Sentiment: neutral

Topics: prospectus, filing, sec-compliance

TL;DR

ImageneBio dropped a 424B3 filing on 4/13/26 - check it for offering details.

AI Summary

ImageneBio, Inc. filed a 424B3 prospectus on April 13, 2026, detailing its offering. The company, located at 12526 High Bluff Drive, San Diego, CA 92130, is involved in Biological Products, excluding diagnostic substances. This filing is part of the company's ongoing regulatory compliance and disclosure process.

Why It Matters

This filing indicates ImageneBio is providing updated prospectus information, which is crucial for investors to understand the terms and conditions of any securities offerings.

Risk Assessment

Risk Level: low — A 424B3 filing is a standard prospectus supplement and does not inherently represent a new risk event.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of a 424B3 filing?

A 424B3 filing is a prospectus supplement used to provide additional information or updates to an already filed registration statement, often detailing terms of securities offerings.

When was this 424B3 filing accepted by the SEC?

This filing was accepted on April 13, 2026, at 08:21:31.

What is ImageneBio, Inc.'s primary business classification?

ImageneBio, Inc. is classified under SIC code 2836, which pertains to Biological Products, excluding diagnostic substances.

Where is ImageneBio, Inc. located?

ImageneBio, Inc.'s mailing and business address is 12526 High Bluff Drive, San Diego, CA 92130.

What is the CIK number for ImageneBio, Inc.?

The CIK number for ImageneBio, Inc. is 0001835579.

Filing Details

This Form 424B3 (Form 424B3) was filed with the SEC on April 13, 2026 regarding ImageneBio, Inc. (IMA).

View full filing on EDGAR

View on Read The Filing